Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Albertsson

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Experimental and Therapeutic Medicine|September 15, 2012
Effective oral combination metronomic chemotherapy with low toxicity for the management of castration-resistant prostate cancerAsa Jellvert, Ingela Franck Lissbrant, Maliha Edgren, et al.
Acta Oncologica (Stockholm, Sweden)|November 4, 2014
Radical prostatectomy versus high-dose irradiation in localized/locally advanced prostate cancer: A Swedish multicenter randomized trial with patient-reported outcomesBo Lennernäs, Khairul Majumder, Jan-Erik Damber, et al.
American Heart Journal|June 23, 2014
Response to the letter to the editor by Ariza-Solé et alMatthijs A Velders, Stefan K James, Berglind Libungan, et al.
EJNMMI Research|April 26, 2017
Therapeutic efficacy of α-radioimmunotherapy with different activity levels of the <sup>213</sup>Bi-labeled monoclonal antibody MX35 in an ovarian cancer modelAnna Gustafsson-Lutz, Tom Bäck, Emma Aneheim, et al.
Nuclear Medicine and Biology|October 1, 2011
Comparison of therapeutic efficacy and biodistribution of 213Bi- and 211At-labeled monoclonal antibody MX35 in an ovarian cancer modelAnna M E Gustafsson, Tom Bäck, Jörgen Elgqvist, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 11, 2018
Sustained risk of stent thrombosis and restenosis in first generation drug-eluting Stents after One Decade of Follow-up: A Report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)Sebastian Völz, Oskar Angerås, Jacob Odenstedt, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 14, 2010
Effects of IL-2 on MMP expression in freshly isolated human NK cells and the IL-2-independent NK cell line YTKarin Edsparr, Frank M Speetjens, Adri Mulder-Stapel, et al.
Journal of the American Heart Association|January 9, 2020
Culprit and Nonculprit Recurrent Ischemic Events in Patients With Myocardial Infarction: Data From SWEDEHEART (Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies)Christoph Varenhorst, Pål Hasvold, Saga Johansson, et al.
Oncotarget|September 9, 2017
Radial artery intima-media thickness regresses after secondary prevention interventions in patients' post-acute coronary syndrome and is associated with cardiac and kidney biomarkersDamilola D Adingupu, Helena U Westergren, Santosh Dahgam, et al.
Immunology and Cell Biology|May 13, 2009
Human NK cell lines migrate differentially in vitro related to matrix interaction and MMP expressionKarin Edsparr, Bengt R Johansson, Ronald H Goldfarb, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Experimental and Therapeutic Medicine|September 15, 2012
Effective oral combination metronomic chemotherapy with low toxicity for the management of castration-resistant prostate cancerAsa Jellvert, Ingela Franck Lissbrant, Maliha Edgren, et al.
Acta Oncologica (Stockholm, Sweden)|November 4, 2014
Radical prostatectomy versus high-dose irradiation in localized/locally advanced prostate cancer: A Swedish multicenter randomized trial with patient-reported outcomesBo Lennernäs, Khairul Majumder, Jan-Erik Damber, et al.
American Heart Journal|June 23, 2014
Response to the letter to the editor by Ariza-Solé et alMatthijs A Velders, Stefan K James, Berglind Libungan, et al.
EJNMMI Research|April 26, 2017
Therapeutic efficacy of α-radioimmunotherapy with different activity levels of the <sup>213</sup>Bi-labeled monoclonal antibody MX35 in an ovarian cancer modelAnna Gustafsson-Lutz, Tom Bäck, Emma Aneheim, et al.
Nuclear Medicine and Biology|October 1, 2011
Comparison of therapeutic efficacy and biodistribution of 213Bi- and 211At-labeled monoclonal antibody MX35 in an ovarian cancer modelAnna M E Gustafsson, Tom Bäck, Jörgen Elgqvist, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 11, 2018
Sustained risk of stent thrombosis and restenosis in first generation drug-eluting Stents after One Decade of Follow-up: A Report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)Sebastian Völz, Oskar Angerås, Jacob Odenstedt, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 14, 2010
Effects of IL-2 on MMP expression in freshly isolated human NK cells and the IL-2-independent NK cell line YTKarin Edsparr, Frank M Speetjens, Adri Mulder-Stapel, et al.
Journal of the American Heart Association|January 9, 2020
Culprit and Nonculprit Recurrent Ischemic Events in Patients With Myocardial Infarction: Data From SWEDEHEART (Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies)Christoph Varenhorst, Pål Hasvold, Saga Johansson, et al.
Oncotarget|September 9, 2017
Radial artery intima-media thickness regresses after secondary prevention interventions in patients' post-acute coronary syndrome and is associated with cardiac and kidney biomarkersDamilola D Adingupu, Helena U Westergren, Santosh Dahgam, et al.
Immunology and Cell Biology|May 13, 2009
Human NK cell lines migrate differentially in vitro related to matrix interaction and MMP expressionKarin Edsparr, Bengt R Johansson, Ronald H Goldfarb, et al.
Pageof 11